NASDAQ:SPHS - Sophiris Bio Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.07 +0.03 (+2.88 %)
(As of 03/18/2019 02:01 PM ET)
Previous Close$1.07
Today's Range$1.07 - $1.07
52-Week Range$0.75 - $4.05
Volume12 shs
Average Volume142,833 shs
Market Capitalization$32.22 million
P/E Ratio-2.75
Dividend YieldN/A
Beta2.94

Analyst Ratings

Sophiris Bio (NASDAQ:SPHS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Sophiris Bio in the last 12 months. Their average twelve-month price target is $4.8333, suggesting that the stock has a possible upside of 351.71%. The high price target for SPHS is $6.00 and the low price target for SPHS is $3.50. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.8333$8.00$8.00$9.00
Price Target Upside: 351.71% upside601.45% upside601.45% upside226.09% upside

Sophiris Bio (NASDAQ:SPHS) Consensus Price Target History

Price Target History for Sophiris Bio (NASDAQ:SPHS)

Sophiris Bio (NASDAQ:SPHS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/14/2019HC WainwrightLower Price TargetBuy$10.00 ➝ $3.50HighView Rating Details
3/13/2019Piper Jaffray CompaniesLower Price TargetOverweight$5.00HighView Rating Details
12/17/2018Maxim GroupSet Price TargetBuy$6.00N/AView Rating Details
6/1/2017Rodman & RenshawReiterated RatingBuy$6.00HighView Rating Details
(Data available from 3/18/2017 forward)
This page was last updated on 3/18/2019 by MarketBeat.com Staff

Featured Article: Buy-Side Analysts

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel